| Product Code: ETC9973161 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Peripheral Arterial Disease Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Peripheral Arterial Disease Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Peripheral Arterial Disease Market - Industry Life Cycle |
3.4 United States (US) Peripheral Arterial Disease Market - Porter's Five Forces |
3.5 United States (US) Peripheral Arterial Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 United States (US) Peripheral Arterial Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Peripheral Arterial Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 United States (US) Peripheral Arterial Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Peripheral Arterial Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lifestyle diseases such as diabetes and obesity leading to a higher incidence of peripheral arterial disease (PAD) in the US. |
4.2.2 Growing aging population in the US, as PAD is more common among older individuals. |
4.2.3 Technological advancements in minimally invasive procedures for the treatment of PAD, improving patient outcomes and driving market growth. |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals and reimbursement policies for PAD treatment options in the US. |
4.3.2 High treatment costs associated with advanced PAD interventions, limiting accessibility for some patient populations. |
5 United States (US) Peripheral Arterial Disease Market Trends |
6 United States (US) Peripheral Arterial Disease Market, By Types |
6.1 United States (US) Peripheral Arterial Disease Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Devices, 2021- 2031F |
6.1.4 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Catheters, 2021- 2031F |
6.1.5 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.6 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Peripheral Arterial Disease Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Peripheral Arterial Disease Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Peripheral Arterial Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 United States (US) Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Peripheral Arterial Disease Market Import-Export Trade Statistics |
7.1 United States (US) Peripheral Arterial Disease Market Export to Major Countries |
7.2 United States (US) Peripheral Arterial Disease Market Imports from Major Countries |
8 United States (US) Peripheral Arterial Disease Market Key Performance Indicators |
8.1 Average length of hospital stay for PAD patients undergoing treatment. |
8.2 Adoption rate of minimally invasive procedures for PAD treatment. |
8.3 Number of PAD awareness campaigns and their impact on early diagnosis rates. |
9 United States (US) Peripheral Arterial Disease Market - Opportunity Assessment |
9.1 United States (US) Peripheral Arterial Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 United States (US) Peripheral Arterial Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Peripheral Arterial Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 United States (US) Peripheral Arterial Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Peripheral Arterial Disease Market - Competitive Landscape |
10.1 United States (US) Peripheral Arterial Disease Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Peripheral Arterial Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here